Efficacy and Safety of Anticoagulation Treatment in COVID-19 Patient Subgroups Identified by Clinical-Based Stratification and Unsupervised Machine Learning: A Matched Cohort Study
Source check: Source checked. Not independent scientific confirmation.
Finding / tested result: retrospective single-center cohort 2,272 COVID-19 patients; propensity matching/IPTW and unsupervised four-cluster stratification; reported heterogeneous anticoagulation associations across clusters, including possible benefit cluster 3. Observational confounding precludes causal treatment claim.
Technology: Machine Learning
Publication: Publication status unspecified in annotation · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.
- AI contribution
- Unsupervised clustering defines subphenotypes that structure a treatment-outcome association; observational analysis, not causal proof.
- Limitation / still unknown
- Affiliation not stated in the reviewed material. Affiliation was not available in the reviewed primary bibliographic metadata. Publication status could not be established from the reviewed primary bibliographic metadata.
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://www.frontiersin.org/journals/medicine/articles/10.3389/fmed.2021.786414/full
The legacy label “Not reported” does not distinguish information absent from reviewed material from information not assessed. It is not a scientific finding of absence.
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.
Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 3/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.